Brukinsa 160 mg

Brukinsa 160 mg tablets contain zanubrutinib, a medication used for certain types of cancer. This oral treatment is designed to target specific proteins in the body.

Brukinsa 160 mg tablets are primarily used in the treatment of various types of cancer. Zanubrutinib, the active ingredient, works by targeting specific proteins involved in the growth and spread of cancer cells. This medication is often prescribed for conditions where these proteins play a significant role. What is Brukinsa used for? It is typically used in the management of certain cancers, helping to slow down the progression of the disease.

Common effects of Brukinsa 160 mg tablets may include fatigue, diarrhea, and upper respiratory tract infections. Some individuals might experience bruising or bleeding more easily. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Brukinsa 160 mg tablets should be handled with care. It is essential to follow the advice of a healthcare professional regarding its use. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies. Always inform your healthcare provider about any other medications you are taking.

Brukinsa 160 mg tablets may interact with certain medications, including those that affect the liver's ability to metabolize drugs. Alcohol and other substances that affect liver enzymes should be avoided. Always consult a healthcare provider before starting or stopping any medication while taking Brukinsa.